Altium Capital Management LP Vera Therapeutics, Inc. Transaction History
Altium Capital Management LP
- $283 Million
- Q3 2024
A detailed history of Altium Capital Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 684,000 shares of VERA stock, worth $33.9 Million. This represents 10.66% of its overall portfolio holdings.
Number of Shares
684,000
Previous 714,000
4.2%
Holding current value
$33.9 Million
Previous $25.8 Million
17.01%
% of portfolio
10.66%
Previous 13.76%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$214 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$195 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$165 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$147 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$138 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.34B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...